Linezolid

This classification denotes an antibiotic with the molecular formula C16H20FN3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ISQ9I6J12J, chemically known as acetamide, n-(((5s)-3-(3-fluoro-4-(4-morpholinyl)phenyl)-2-oxo-5-oxazolidinyl)methyl)- but generally known as linezolid, which bears US NIH Compound Identifier 73180. European Medicines Agency schedules Linezolid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08520MIG. The term LINEZOLID is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 11, No. 3 1997, List 38). World Health Organization schedules linezolid in its Anatomical Therapeutic Chemical (ATC) Classification. LINEZOLID is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule linezolid under HS 29349990 and SITC 51579. As of Q4 2014, LINEZOLID remains the US FDA Preferred Term for this commodity. Linezolid bears US NLM identifiers UMLS ID C0663241 and NCI Concept Code C29158. SMILES: FC1C(N2CCOCC2)CCC(N2CC(OC2=O)CNC(=O)C)C1.